Primary liver cancer is one of malignant tumor, with rapid progression, poor prognosis etc.. The emergence of molecularly targeted drugs and sorafenib, become one of the powerful weapon against liver cancer clinicians cannot operation. Sola Fini is currently the first and only a America FDA and Chinese approved SFDA liver cancer targeted therapy drugs, by many international authoritative guide recommended for advanced hepatocellular carcinoma with standard treatment, bring life sustaining hope for patients with hepatocellular carcinoma.
Liver cancer is a systemic disease, multidisciplinary treatment is very important. The meeting, with the participation of leaders in the treatment of liver cancer in various fields together in-depth study of liver cancer diagnosis, treatment process of multi subject cooperation idea, the new progress and related departments.